HIKAL
Quarterly Results Analysis [Mar2024]
HIKAL Quarterly Results
Consolidated | Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
Dec2022 UnAudited |
Sep2022 UnAudited |
Jun2022 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹514 Cr | ₹448 Cr | ₹435 Cr | ₹388 Cr | ₹545 Cr | ₹540 Cr | ₹559 Cr | ₹379 Cr |
Expenses | ₹420 Cr | ₹383 Cr | ₹377 Cr | ₹338 Cr | ₹457 Cr | ₹466 Cr | ₹489 Cr | ₹356 Cr |
Operating Income | ₹94 Cr | ₹65 Cr | ₹58 Cr | ₹50 Cr | ₹88 Cr | ₹75 Cr | ₹70 Cr | ₹23 Cr |
Other Income | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹3 Cr | ₹1 Cr | ₹3 Cr |
Interest | ₹15 Cr | ₹14 Cr | ₹13 Cr | ₹14 Cr | ₹13 Cr | ₹13 Cr | ₹11 Cr | ₹11 Cr |
Depreciation | ₹32 Cr | ₹29 Cr | ₹29 Cr | ₹28 Cr | ₹27 Cr | ₹28 Cr | ₹27 Cr | ₹27 Cr |
Profit Before Tax | ₹47 Cr | ₹22 Cr | ₹17 Cr | ₹10 Cr | ₹49 Cr | ₹36 Cr | ₹33 Cr | ₹-12 Cr |
Profit After Tax | ₹34 Cr | ₹16 Cr | ₹13 Cr | ₹7 Cr | ₹36 Cr | ₹26 Cr | ₹25 Cr | ₹-9 Cr |
EPS | ₹2.76 | ₹1.31 | ₹1.02 | ₹0.56 | ₹2.92 | ₹2.14 | ₹2.01 | ₹-0.72 |
Industry Peers & Returns | 1W | 1M | 1Y |
HIKAL | -3.2% | -5.4% | -5.8% |
SUN PHARMACEUTICAL INDUSTRIES | 0.7% | -4.8% | 57.3% |
CIPLA | 1.9% | -2.4% | 42.6% |
DR REDDYS LABORATORIES | -5.4% | -4.1% | 20% |
ZYDUS LIFESCIENCES | 1.3% | 0.5% | 87.4% |
DIVIS LABORATORIES | 0.1% | 3% | 12.1% |
MANKIND PHARMA | -1.7% | -7.8% | 57.2% |
TORRENT PHARMACEUTICALS | -0.5% | 1% | 57.7% |
LUPIN | 4.8% | 5.2% | 115.9% |
HIKAL Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 14.86 % |
Y-o-Y | -5.72 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Mar2024 | ₹514 Cr | 14.86 | |
Dec2023 | ₹448 Cr | 2.92 | |
Sep2023 | ₹435 Cr | 12.07 | |
Jun2023 | ₹388 Cr | -28.84 | |
Mar2023 | ₹545 Cr | 0.94 | |
Dec2022 | ₹540 Cr | -3.32 | |
Sep2022 | ₹559 Cr | 47.51 | |
Jun2022 | ₹379 Cr | - |
HIKAL Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 45.86 % |
Y-o-Y | 7.33 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Mar2024 | ₹94 Cr | 45.86 | |
Dec2023 | ₹65 Cr | 12.59 | |
Sep2023 | ₹58 Cr | 14.38 | |
Jun2023 | ₹50 Cr | -42.86 | |
Mar2023 | ₹88 Cr | 18.01 | |
Dec2022 | ₹75 Cr | 6.96 | |
Sep2022 | ₹70 Cr | 206.51 | |
Jun2022 | ₹23 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 26.95 % |
Y-o-Y | 13.82 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Mar2024 | 18.37% | 26.95 | |
Dec2023 | 14.47% | 9.37 | |
Sep2023 | 13.23% | 2.08 | |
Jun2023 | 12.96% | -19.70 | |
Mar2023 | 16.14% | 16.87 | |
Dec2022 | 13.81% | 10.66 | |
Sep2022 | 12.48% | 107.65 | |
Jun2022 | 6.01% | - |
HIKAL Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 110.47 % |
Y-o-Y | -5.64 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Mar2024 | ₹34 Cr | 110.47 | |
Dec2023 | ₹16 Cr | 28.40 | |
Sep2023 | ₹13 Cr | 81.65 | |
Jun2023 | ₹7 Cr | -80.78 | |
Mar2023 | ₹36 Cr | 36.31 | |
Dec2022 | ₹26 Cr | 6.32 | |
Sep2022 | ₹25 Cr | Positive | |
Jun2022 | ₹-9 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 83.10 % |
Y-o-Y | 0.15 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2024 | 6.61 % | 83.10 | |
Dec2023 | 3.61 % | 24.91 | |
Sep2023 | 2.89 % | 62.36 | |
Jun2023 | 1.78 % | -73.03 | |
Mar2023 | 6.6 % | 34.97 | |
Dec2022 | 4.89 % | 9.89 | |
Sep2022 | 4.45 % | Positive | |
Jun2022 | -2.34 % | - |
HIKAL Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 110.69 % |
Y-o-Y | -5.48 % |
Quarters | EPS | % Change | |
---|---|---|---|
Mar2024 | ₹2.76 | 110.69 | |
Dec2023 | ₹1.31 | 28.43 | |
Sep2023 | ₹1.02 | 82.14 | |
Jun2023 | ₹0.56 | -80.82 | |
Mar2023 | ₹2.92 | 36.45 | |
Dec2022 | ₹2.14 | 6.47 | |
Sep2022 | ₹2.01 | Positive | |
Jun2022 | ₹-0.72 | - |
You may also like the below Video Courses